Corinna Kosnopfel

Muenster, NW 48149, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Combinatorial ERK Inhibition Enhances MAPK Pathway Suppression in BRAF-Mutant Melanoma.

Combinatorial ERK Inhibition Enhances MAPK Pathway Suppression in BRAF-Mutant Melanoma.

Journal: International journal of molecular sciences
Published: April 14, 2025

LNS-8801 as a therapeutic agent for aggressive lymphomas: ROS-induced cytotoxicity and synergy with existing therapies.

LNS-8801 as a therapeutic agent for aggressive lymphomas: ROS-induced cytotoxicity and synergy with existing therapies.

Journal: Blood advances
Published: February 11, 2025

Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils.

Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils.

Journal: Cancers
Published: April 08, 2024

Loss of p14 diminishes immunogenicity in melanoma via non-canonical Wnt signaling by reducing the peptide surface density.

Loss of p14 diminishes immunogenicity in melanoma via non-canonical Wnt signaling by reducing the peptide surface density.

Journal: Molecular oncology
Published: January 03, 2024

Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma.

Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma.

Journal: Cancers
Published: September 22, 2023

Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion.

Inhibition of p90 ribosomal S6 kinases disrupts melanoma cell growth and immune evasion.

Journal: Journal of experimental & clinical cancer research : CR
Published: May 04, 2023

Biomechanical and biochemical assessment of YB-1 expression in A375 melanoma cell line: Exploratory study.

Biomechanical and biochemical assessment of YB-1 expression in A375 melanoma cell line: Exploratory study.

Journal: Frontiers in molecular medicine
Published: September 21, 2022

mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma.

mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphoma.

Journal: Leukemia
Published: June 17, 2022

Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma.

Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma.

Journal: Cancers
Published: March 31, 2022

Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen-activated protein kinase pathway.

Cutaneous epithelioid haemangiomas show somatic mutations in the mitogen-activated protein kinase pathway.

Journal: The British journal of dermatology
Published: October 29, 2021

Single-cell trajectories of melanoma cell resistance to targeted treatment.

Single-cell trajectories of melanoma cell resistance to targeted treatment.

Journal: Cancer biology & medicine
Published: September 30, 2021

Targeting the Y-box Binding Protein-1 Axis to Overcome Radiochemotherapy Resistance in Solid Tumors.

Targeting the Y-box Binding Protein-1 Axis to Overcome Radiochemotherapy Resistance in Solid Tumors.

Journal: International journal of radiation oncology, biology, physics
Published: February 26, 2021
Showing 1-12 of 24

Last Updated: 09/26/2026